Sounds good but it's 3 million out of QBL/MCL coughers for this research over 3 years, we need to be bringing in some serious revenue if we are potentially going to fund this & also the first million for Canntab should it be realized here in Australia & Asia.
Looking forward to seeing some revenue figures or announcements that are going to raise revenue in the short to medium term, I agree its critical to invest in the future but the books need to reflect our capacity to do so, don't want to extend ourselves beyond means.
I got a good feeling sales are going to be strong though! I have faith in QBL & Andrew to make the right calls.
- Forums
- ASX - By Stock
- CGB
- Ann: A World First for MCL in Autoimmune Disease Reasearch
Ann: A World First for MCL in Autoimmune Disease Reasearch, page-5
-
- There are more pages in this discussion • 274 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)